IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation

Ahmed E. I. Hamouda, Kai Schulze, Thomas Ebensen, Carlos Alberto Guzmán, Darío Lirussi

Open source

DOI
10.3390/pharmaceutics14122821
Published
2022-12-16
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics14122821,
  title = {IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation},
  author = {Ahmed E. I. Hamouda and Kai Schulze and Thomas Ebensen and Carlos Alberto Guzmán and Darío Lirussi},
  year = {2022},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics14122821},
  url = {https://doi.org/10.3390/pharmaceutics14122821}
}

RIS

TY  - JOUR
TI  - IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation
AU  - Ahmed E. I. Hamouda
AU  - Kai Schulze
AU  - Thomas Ebensen
AU  - Carlos Alberto Guzmán
AU  - Darío Lirussi
PY  - 2022
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics14122821
UR  - https://doi.org/10.3390/pharmaceutics14122821
ER  - 

APA

Hamouda, A. E. I., Schulze, K., Ebensen, T., Guzmán, C. A., & Lirussi, D. (2022). IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14122821

Source records